Picilorex
 | |
| Clinical data | |
|---|---|
| Other names | UP 507-04 |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C14H18ClN |
| Molar mass | 235.76 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Picilorex (INN; brand name Roxenan; IUPAC: 3-(4-Chlorophenyl)-5-cyclopropyl-2-methylpyrrolidine)[1] is an anorectic which is no longer marketed.[2][3][4] It is a monoamine reuptake inhibitor, a stimulant as well as a derivate of Pyrrolidine.[3]
See also
- α-PHP
- α-PHPP
- Pyrovalerone
- Prolintane
- Rolicyclidine (PCPy)
- MDPV
- List of aminorex analogues
- Substituted phenylmorpholine
References
- ^ PubChem. "Cyclopropyl-2 p-chlorophenyl-4 methyl-5 pyrrolidine succinate". pubchem.ncbi.nlm.nih.gov. Archived from the original on 2021-05-31. Retrieved 2021-05-31.
- ^ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 1599–. ISBN 978-0-412-46630-4.
- ^ a b Milne GW (1 January 2001). Ashgate Handbook of Autonomic Nervous System Agents. Wiley. ISBN 978-0-566-08384-6.
- ^ World Health Organization (2000). International Nonproprietary Names (INN) for Pharmaceutical Substances. World Health Organization. ISBN 978-0-11-986227-0. Archived from the original on 2019-07-14. Retrieved 2016-10-16.